DETERMINE Trial Treatment Arm 07: Dabrafenib in Combination With Trametinib in Adult, Paediatric and Teenage/Young Adult Patients With BRAF V600 Mutation-Positive Cancers.

NCT07440290 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

NOT_YET_RECRUITING

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Haematological Malignancy
Malignant Neoplasm
Lymphoproliferative Disorders
Neoplasms by Histologic Type
Neoplasms by Site
Gastrointestinal Cancer
Non-Melanoma Skin Cancer (NMSC)
Langerhans Cell Histiocytosis (LCH)
Cancer
Erdheim-Chester Disease
Thyroid Carcinoma, Papillary
Ovarian Neoplasms
Colorectal Neoplasms
Laryngeal Neoplasms
Carcinoma, Non-Small Cell-Lung
Glioma
Multiple Myeloma
Thyroid Carcinoma, Anaplastic
Solid Tumour

Interventions

DRUG: Dabrafenib
DRUG: Trametinib

Sponsor

Cancer Research UK

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]